CClinicalTrials.gg
Status unknownNCT02701855EYEBRAINUpdated Mar 8, 2016

Retina Microvascular Remodeling and Cognitive Function In Hypertension

An observational study in Hypertension and Mild Cognitive Impairment, sponsored by Institute of Cardiometabolism and Nutrition, France. Status unknown at 1 site in France. Open to participants aged 65 Years and older. Per ClinicalTrials.gov, last updated 2016-03-08.

Sponsored by Institute of Cardiometabolism and Nutrition, France · Observational

The sponsor has not verified this record recently (last verified Mar 2016), so the status shown — last known as Recruiting — may be out of date.
Study type
Observational
Model
Case-only
Time perspective
Prospective
Enrollment
160
Ages
65 Years and older
Sex
All
01

Study summary

This study aims to determine the relationships between retina micro-vascular remodeling and cognitive function in hypertensive patients.

The study plans to enrol 160 patients (100 patients with mild cognitive impairment -MCI- and 60 without MCI).

Read the detailed description

Our project stands on physiopathological and cognitive angles, and is mainly based on the major role of large and small arteries elasticity on cognitive aging. It will benefit from the recent innovative accurate and non invasive techniques such as MRI for central large arteries and adaptative optics for retina arterioles imaging.

Study population is the following:

  • 60 patients with hypertension and no MCI,
  • 50 patients with hypertension and stable MCI, without dementia
  • 50 patients with hypertension and progressive MCI, without dementia

Every patients will perform a medical interview and examination, an MRI (brain + aorta), adaptative optics imaging, a cognitive tests and a blood test.

Primary outcome is to determine the relationships between retina micro-vascular remodeling and cognitive function in this population.

02

Conditions studied

  • Hypertension
  • Mild Cognitive Impairment
03

In context

Hypertension

6,689 studies on the registry are indexed under Hypertension; 965 are open to participants now.

This study's planned enrollment of 160 is below the median of 210 across 1,359 observational studies indexed under Hypertension.

Browse Hypertension studies →

Lead sponsor

Institute of Cardiometabolism and Nutrition, France is the lead sponsor of 3 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
65 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

Patients' recruitment will be carried out in two centers to ensure inclusion of both patients: 1) with hypertension and without cognitive impairment, 2) with hypertension and with mild cognitive impairment (without dementia) including patients with stable MCI and converters.

Population size: 160 patients:

  • 60 patients with hypertension and no MCI,
  • 50 patients with hypertension and stable MCI, without dementia
  • 50 patients with hypertension and progressive MCI, without dementia

Inclusion criteria

  1. Aged 65 or more
  2. hypertension (BP ≥140/90 mmHg and/or antihypertensive treatment)
  3. Signed informed consent by the patient
  4. Sufficient mastery of the French language to perform neuropsychological tests

Exclusion criteria

Exclusion Criteria:

  1. Impossibility to visualize the retinal : severe cataract
  2. Dementia (defined by MMSE\<20)
  3. Clinical stroke
  4. Severe or resistant Hypertension
  5. Hypertension treated with more than 3 different pharmacological classes
  6. any other disease that may interfere with the assessment of cognitive disorders (epilepsy, Parkinson's disease, major depression, schizophrenia, manic-depressive)
  7. Enrolment in a therapeutic trial that could interfere with the main objective
  8. Less than 4 years of formal education
  9. Illiterate, unable to read, write or count
  10. major physical problems that may interfere with the tests (sight, hearing, ...)
  11. Short term life threatening disease
  12. Non-affiliation to a healthcare system
  13. Consent refusal
  14. Contraindication to MRI including claustrophobia, metallic devices, pacemaker, mechanical valve implanted before 1985, and nursing, as well as technical contra-indication: patient diameter > 70 cm or/and weight > 250 kg
05

Study design

Observational model
Case-only
Time perspective
Prospective
Enrollment
160 participants (estimated)
Patient registry
No

Groups and cohorts

  • Hypertension and progressive MCI

    50 subjects will perform brain and aorta RMI, blood test, cognitive tests and adaptative optics.

    Behavioral: Cognitive tests · Biological: Blood test · Radiation: Brain and aorta RMI · Other: Adaptative optics

  • Hypertension and stable MCI

    50 subjects will perform brain and aorta RMI, blood test, cognitive tests and adaptative optics.

    Behavioral: Cognitive tests · Biological: Blood test · Radiation: Brain and aorta RMI · Other: Adaptative optics

  • Hypertension, without MCI

    60 subjects will perform brain and aorta RMI, blood test, cognitive tests and adaptative optics.

    Behavioral: Cognitive tests · Biological: Blood test · Radiation: Brain and aorta RMI · Other: Adaptative optics

Interventions

  • BehavioralCognitive tests

    Cognitive tests include: * The MMSE (Mini Mental State Examination) * Free and Cued Selective Recall Reminding Test (FCSRT). * Executive functions (fluencies, TMT A and B, span). * Tests of verbal fluency (literal and category) * Digit symbol substitution test or Wechsler adult intelligence scale (W.A.I.S) * The Clinical Dementia Rating Scale * The IADL scale evaluates autonomy. * Geriatric Depression screening Scale (GDS)

  • BiologicalBlood test

    A blood test will be performed in order to collect following parameters: Urea, BUN, Creatinine, Potassium, Sodium, hematocrit, hsCRP, NFS, Pq, LDL-C, HDL-C, Triglycerides, Lp(a), Lp-PLA2 as well as fasting glucose, HbA1C and microalbuminuria

  • RadiationBrain and aorta RMI

    A magnetic resonance imaging exam will be performed at the Neuroimaging Research Center of the Pitié-Salpêtrière Hospital. This exam will be optimized to fit in 30 minutes. Indeed brain 3D T1 and T2 FLAIR imaging lasts 15 minutes while cine and velocity encoded imaging of the aorta lasts 15 minutes.

  • OtherAdaptative optics

    The retina adaptative optic imaging will be performed at the "Unité de prevention des maladies cardiovasculaires" Pitié Salpetrière Hospital. This exam lasts 10 minutes including patient positioning and imaging.

06

What researchers measure

Primary outcomes

  1. Relationships between retina micro-vascular remodeling and cognitive function in hypertensive patients.

    Time frame: September 2017

Secondary outcomes

  1. • Associations between cognitive function and proximal aortic stiffness indices estimated from MRI images.

    Time frame: September 2017

  2. • Associations between retina arteriolar remodelling and cerebrovascular lesions (infarcts, lacuna, and white matter lesions) quantified from MRI images.

    Time frame: September 2017

  3. • Associations between retina arteriolar remodelling and neurodegenerative lesions (hippocampus atrophy) quantified from MRI images.

    Time frame: September 2017

  4. • Associations between proximal aortic stiffness and cerebrovascular lesions (infarcts, lacuna, and white matter lesions) quantified from MRI images.

    Time frame: September 2017

  5. • Associations between proximal aortic stiffness and neurodegenerative lesions (hippocampus atrophy) quantified from MRI images.

    Time frame: September 2017

  6. • Associations between retina arteriolar remodelling and proximal aortic stiffness indices.

    Time frame: September 2017

07

Study locations

1 of 1 sites recruiting
  • Unité de prévention des maladies cardiovasculaires Pôle Cardiologie/Métabolisme Hôpital Pitié-Salpétriêre, APHP, 83 bd de l'hôpital,
    Paris, 75013, France
    • David Rosenbaum, Dr · Contact
    Recruiting
08

References and documents

Publications

  • Ferri CP, Prince M, Brayne C, Brodaty H, Fratiglioni L, Ganguli M, Hall K, Hasegawa K, Hendrie H, Huang Y, Jorm A, Mathers C, Menezes PR, Rimmer E, Scazufca M; Alzheimer's Disease International. Global prevalence of dementia: a Delphi consensus study. Lancet. 2005 Dec 17;366(9503):2112-7. doi: 10.1016/S0140-6736(05)67889-0. PubMed 16360788 ↗
  • Luchsinger JA, Reitz C, Honig LS, Tang MX, Shea S, Mayeux R. Aggregation of vascular risk factors and risk of incident Alzheimer disease. Neurology. 2005 Aug 23;65(4):545-51. doi: 10.1212/01.wnl.0000172914.08967.dc. PubMed 16116114 ↗
  • Launer LJ, Ross GW, Petrovitch H, Masaki K, Foley D, White LR, Havlik RJ. Midlife blood pressure and dementia: the Honolulu-Asia aging study. Neurobiol Aging. 2000 Jan-Feb;21(1):49-55. doi: 10.1016/s0197-4580(00)00096-8. PubMed 10794848 ↗
  • Qiu C, Winblad B, Fratiglioni L. The age-dependent relation of blood pressure to cognitive function and dementia. Lancet Neurol. 2005 Aug;4(8):487-99. doi: 10.1016/S1474-4422(05)70141-1. PubMed 16033691 ↗
  • Perlmutter LS, Barron E, Saperia D, Chui HC. Association between vascular basement membrane components and the lesions of Alzheimer's disease. J Neurosci Res. 1991 Dec;30(4):673-81. doi: 10.1002/jnr.490300411. PubMed 1787541 ↗
  • Hardy JA, Mann DM, Wester P, Winblad B. An integrative hypothesis concerning the pathogenesis and progression of Alzheimer's disease. Neurobiol Aging. 1986 Nov-Dec;7(6):489-502. doi: 10.1016/0197-4580(86)90086-2. PubMed 2882432 ↗
  • Vagnucci AH Jr, Li WW. Alzheimer's disease and angiogenesis. Lancet. 2003 Feb 15;361(9357):605-8. doi: 10.1016/S0140-6736(03)12521-4. PubMed 12598159 ↗
  • Hanon O, Haulon S, Lenoir H, Seux ML, Rigaud AS, Safar M, Girerd X, Forette F. Relationship between arterial stiffness and cognitive function in elderly subjects with complaints of memory loss. Stroke. 2005 Oct;36(10):2193-7. doi: 10.1161/01.STR.0000181771.82518.1c. Epub 2005 Sep 8. PubMed 16151027 ↗
  • Redheuil A, Yu WC, Wu CO, Mousseaux E, de Cesare A, Yan R, Kachenoura N, Bluemke D, Lima JA. Reduced ascending aortic strain and distensibility: earliest manifestations of vascular aging in humans. Hypertension. 2010 Feb;55(2):319-26. doi: 10.1161/HYPERTENSIONAHA.109.141275. Epub 2010 Jan 11. PubMed 20065154 ↗
  • Redheuil A, Yu WC, Mousseaux E, Harouni AA, Kachenoura N, Wu CO, Bluemke D, Lima JA. Age-related changes in aortic arch geometry: relationship with proximal aortic function and left ventricular mass and remodeling. J Am Coll Cardiol. 2011 Sep 13;58(12):1262-70. doi: 10.1016/j.jacc.2011.06.012. PubMed 21903061 ↗
  • Rosenbaum D, Koch E, Girerd X, Rossant F, Paques M. [Imaging of retinal arteries with adaptative optics, feasibility and reproducibility]. Ann Cardiol Angeiol (Paris). 2013 Jun;62(3):184-8. doi: 10.1016/j.ancard.2013.04.017. Epub 2013 May 29. French. PubMed 23773704 ↗
  • Herment A, Kachenoura N, Lefort M, Bensalah M, Dogui A, Frouin F, Mousseaux E, De Cesare A. Automated segmentation of the aorta from phase contrast MR images: validation against expert tracing in healthy volunteers and in patients with a dilated aorta. J Magn Reson Imaging. 2010 Apr;31(4):881-8. doi: 10.1002/jmri.22124. PubMed 20373432 ↗
  • Bollache E, Kachenoura N, Redheuil A, Frouin F, Mousseaux E, Recho P, Lucor D. Descending aorta subject-specific one-dimensional model validated against in vivo data. J Biomech. 2014 Jan 22;47(2):424-31. doi: 10.1016/j.jbiomech.2013.11.009. Epub 2013 Nov 15. PubMed 24290136 ↗
  • Dogui A, Kachenoura N, Frouin F, Lefort M, De Cesare A, Mousseaux E, Herment A. Consistency of aortic distensibility and pulse wave velocity estimates with respect to the Bramwell-Hill theoretical model: a cardiovascular magnetic resonance study. J Cardiovasc Magn Reson. 2011 Jan 27;13(1):11. doi: 10.1186/1532-429X-13-11. PubMed 21272312 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 8, 2016, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02701855
Lead sponsor
Institute of Cardiometabolism and Nutrition, France
Collaborators
Fondation de Recherche sur l'Hypertension Artérielle
Responsible party
Sponsor
First posted
Mar 8, 2016
Start date
Oct 2014
Primary completion
Sep 2017 (estimated)
Completion
Dec 2017 (estimated)
Last update
Mar 8, 2016

Study contacts

David Rosenbaum, Dr
Contact
david.rosenbaum@psl.aphp.fr
01 42 17 57 74 ext. +33

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Mar 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion